KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) EBIT Margin: 2009-2024

Historic EBIT Margin for Chemed (CHE) over the last 16 years, with FY2024 value amounting to 15.07%.

  • Chemed's EBIT Margin fell 32400.0% to 11.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.89%, marking a year-over-year decrease of 14200.0%. This contributed to the annual value of 15.07% for FY2024, which is 300.0% up from last year.
  • Latest data reveals that Chemed reported EBIT Margin of 15.07% as of FY2024, which was up 300.0% from 15.04% recorded in FY2023.
  • Chemed's 5-year EBIT Margin high stood at 2319.52% for FY2020, and its period low was 15.04% during FY2023.
  • Over the past 5 years, Chemed's median EBIT Margin value was 16.04% (recorded in 2021), while the average stood at 476.35%.
  • In the last 5 years, Chemed's EBIT Margin tumbled by -23034900bps in 2021 and then surged by 500bps in 2022.
  • Over the past 5 years, Chemed's EBIT Margin (Annual) stood at 2319.52% in 2020, then plummeted by -99bps to 16.04% in 2021, then rose by 0bps to 16.09% in 2022, then dropped by -7bps to 15.04% in 2023, then grew by 0bps to 15.07% in 2024.
  • Its EBIT Margin stands at 15.07% for FY2024, versus 15.04% for FY2023 and 16.09% for FY2022.